 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This indicator may be signaling that SIBN's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

SI-BONE (SIBN, $21.21) entered Downtrend as Momentum indicator drops below 0 level on Sep 25, 2023

This is a Bearish indicator signaling SIBN's price could decline from here. Traders may explore shorting the stock or put options...

SI-BONE (SIBN, $21.21) Moving Average Convergence Divergence (MACD) Histogram turned negative on September 25, 2023

This indicator may be signaling SIBN's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

SI-BONE (SIBN, $21.21) entered Uptrend as Momentum indicator ascends above 0 level on Sep 21, 2023

SI-BONE (SIBN, $21.87) entered Downtrend as Momentum indicator drops below 0 level on Sep 20, 2023

SI-BONE (NASDAQ:SIBN  Get Free Report) and Sigyn Therapeutics (OTCMKTS:SIGY  Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the...

SI-BONE (NASDAQ:SIBN) and Sigyn Therapeutics (OTCMKTS:SIGY) Critical Survey

SI-BONE (SIBN, $22.33) entered Uptrend as Momentum indicator ascends above 0 level on Sep 12, 2023

SI-BONE, Inc. (NASDAQ:SIBN  Get Free Report) has received an average rating of Buy from the seven research firms that are currently covering the company, MarketBeat Ratings...

SI-BONE, Inc. (NASDAQ:SIBN) Receives Consensus Recommendation of "Buy" from Brokerages

SI-BONE (SIBN, $21.17) entered Downtrend as Momentum indicator drops below 0 level on Sep 07, 2023

Russell Investments Group Ltd. reduced its stake in shares of SI-BONE, Inc. (NASDAQ:SIBN  Free Report) by 18.2% during the 1st quarter, HoldingsChannel reports. The fund owned 21,461 shares...

Russell Investments Group Ltd. Trims Stake in SI-BONE, Inc. (NASDAQ:SIBN)

SI-BONE: Another Record Quarter, Reinvesting For Future Growth, Reiterate Buy

SI-BONE, Inc. engages in the provision of implantable devices used in the surgical treatment of the sacropelvic anatomy. It offers a proprietary minimally invasive surgical implant system, called iFuse, used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 2008 and is headquartered in Santa Clara, CA.

Watchers	178
52-Wk Low	$11.14
52-Wk High	$29.51

Market Cap	$851.78M
Volume (M)	360,779.00
52-Wk High	$29.51
52-Wk Low	$11.14

SIBN SI-BONE Inc

About

Feed

News

Sentiment

Earnings

Fundamentals